The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Rzaeva K.A.

Meshalkin National Medical Research Center

Arkhipov A.N.

National Medical Research Center

Gorbatykh A.V.

National Medical Research Center

Voitov A.V.

Meshalkin National Medical Research Center

Nichay N.R.

Meshalkin National Medical Research Center

Novikova A.P.

Novosibirsk State Medical University

Timchenko T.P.

Meshalkin National Medical Research Center

Soynov I.A.

Meshalkin National Medical Research Center

Indications for surgical correction and results of transcatheter valve implantation in patients with obstructive pulmonary blood flow pathology

Authors:

Rzaeva K.A., Arkhipov A.N., Gorbatykh A.V., Voitov A.V., Nichay N.R., Novikova A.P., Timchenko T.P., Soynov I.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(4): 344‑351

DOI: 10.17116/kardio202215041344

Views: 1647

Downloaded: 17

Download PDF (RU)
Contact the author
Table of contents

INDICATIONS FOR SURGICAL CORRECTION AND RESULTS OF TRANSCATHETER VALVE IMPLANTATION IN PATIENTS WITH OBSTRUCTIVE PULMONARY BLOOD FLOW PATHOLOGY
INDICATIONS FOR SURGICAL CORRECTION AND RESULTS OF TRANSCATHETER VALVE IMPLANTATION IN PATIENTS WITH OBSTRUCTIVE PULMONARY BLOOD FLOW PATHOLOGY

To cite this article:

Rzaeva KA, Arkhipov AN, Gorbatykh AV, et al. . Indications for surgical correction and results of transcatheter valve implantation in patients with obstructive pulmonary blood flow pathology. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(4):344‑351. (In Russ.)
https://doi.org/10.17116/kardio202215041344

Подписка 2025-2 (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Close metadata
Recommended articles:
The role of gene poly­morphism in hemo­static diso­rders in children unde­rgoing cardiac surgery. Russian Journal of Anesthesiology and Reanimatology. 2024;(3):43-48
Evaluation of the effe­ctiveness and safety of aero­bic cyclical trainings in children after surgical correction of congenital heart diseases and features of short-term adaptation depe­nding on the type of pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):19-31

Repair of right ventricular outflow tract into pulmonary artery through surgical implantation of the valved conduit ensures successful correction of such complex congenital heart defects as pulmonary artery atresia with or without ventricular septal defect, tetralogy of Fallot, common arterial trunk, transposition of the great arteries, pulmonary artery stenosis, as well as congenital anomalies of aortic valve with previous Ross procedure. Degeneration of bioprostheses and valvular conduits leads to progressive dysfunction of the right ventricular outflow tract. Transcatheter pulmonary valve implantation is recognized as a feasible and low risk alternative to surgery considering high risk of intra- and postoperative complications. We present a literature review devoted to indications for transcatheter pulmonary valve implantation and results of this intervention.

Keywords:

congenital heart disease
right ventricular outflow tract/pulmonary valve dysfunction
transcatheter pulmonary valve implantation

Authors:

Rzaeva K.A.

Meshalkin National Medical Research Center

Arkhipov A.N.

National Medical Research Center

Gorbatykh A.V.

National Medical Research Center

Voitov A.V.

Meshalkin National Medical Research Center

Nichay N.R.

Meshalkin National Medical Research Center

Novikova A.P.

Novosibirsk State Medical University

Timchenko T.P.

Meshalkin National Medical Research Center

Soynov I.A.

Meshalkin National Medical Research Center

Received:

14.11.2021

Accepted:

11.12.2021

List of references:

  1. Boethig D, Goerler H, Westhoff-Bleck M, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur J Cardiothorac Surg. 2007;32(1):133-142.  https://doi.org/10.1016/j.ejcts.2007.02.025
  2. Soynov IA, Zhuravleva IYu, Kulyabin YuYu, et al. Valved conduits in pediatric cardiac surgery. Khirurgiia (Mosk). 2018;1:75-81. (In Russ.). https://doi.org/10.17116/hirurgia2018175-81
  3. Breymann T, Boethig D, Goerg R, Thies WR. The Contegra bovine valved jugular vein conduit for pediatric RVOT reconstruction: 4 years experience with 108 patients. J Card Surg. 2004;19(5):426-431.  https://doi.org/10.1111/j.0886-0440.2004.04083.x
  4. Brown JW, Ruzmetov M, Rodefeld MD, et al. Contegra versus pulmonary homografts for right ventricular outflow tract reconstruction: a ten-year single-institution comparison. World J Pediatr Congenit Heart Surg. 2011;2(4):541-549.  https://doi.org/10.1177/2150135111415711
  5. Dave H, Mueggler O, Comber M, et al. Risk factor analysis of 170 single-institutional contegra implantations in pulmonary position. Ann Thorac Surg. 2011;91(1):195-302.  https://doi.org/10.1016/j.athoracsur.2010.07.058
  6. Nath DS, Nussbaum DP, Yurko C, et al. Pulmonary homograft monocusp reconstruction of the right ventricular outflow tract: outcomes to the intermediate term. Ann Thorac Surg. 2010;90(1):42-49.  https://doi.org/10.1016/j.athoracsur.2010.03.045
  7. Boethig D, Schreiber C, Hazekamp M, et al. Risk factors for distal Contegra stenosis: results of a prospective European multicentre study. Thorac Cardiovasc Surg. 2012;60(3):195-204.  https://doi.org/10.1055/s-0031-1298062
  8. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356:1403-1405. https://doi.org/10.1016/s0140-6736(00)02844-0
  9. Baumgartner H, De Backer J, Babu-Narayan SV, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42(6):563-645.  https://doi.org/10.1093/eurheartj/ehaa554
  10. Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot: the quest continues. Circulation. 2013;128(17):1855-1857. https://doi.org/10.1161/CIRCULATIONAHA.113.005878
  11. Kanter KR, Budde JM, Parks WJ, et al. One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. Ann Thorac Surg. 2002;73(6):1801-1806; discussion 1806-1807. https://doi.org/10.1016/s0003-4975(02)03568-3
  12. Lange R, Weipert J, Homann M, et al. Performance of allografts and xenografts for right ventricular outflow tract reconstruction. Ann Thorac Surg. 2001;71(5 suppl):365-367.  https://doi.org/10.1016/s0003-4975(01)02552-8
  13. Therrien J, Siu SC, McLaughlin PR, et al. Pulmonary valve replacement in adults late after repair of tetralogy of fallot: are we operating too late? J Am Coll Cardiol. 2000;36(5):1670-1675. https://doi.org/10.1016/s0735-1097(00)00930-x
  14. Cavalcanti F, Sá MP, Santos CA, et al. Pulmonary valve replacement after operative repair of tetralogy of Fallot: meta-analysis and meta-regression of 3,118 patients from 48 studies. J Am Coll Cardiol. 2013;62(23):2227-2243. https://doi.org/10.1016/j.jacc.2013.04.107
  15. Valente AM, Gauvreau K, Assenza GE, et al. Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort. Heart. 2014;100(3):247-253.  https://doi.org/10.1136/heartjnl-2013-304958
  16. Gillespie MJ, Rome JJ, Levi DS, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv. 2012;5:862-870.  https://doi.org/10.1161/circinterventions.112.972216
  17. Webb JG, Wood DA, Ye J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848-1857. https://doi.org/10.1161/circulationaha.109.924613
  18. Bonhoeffer P. 2009 RVOT dysfunction: future perspectives Workshop IPC and ISHAC Joint Meeting, Milan, Italy. https://www.abmedica.it/workshopipc/7th_workshop/video/0051.wmv
  19. Witold R, Biernacka EK, Woźniak O, et al. Transcatheter pulmonary valve implantation in 100 patients: a 10-year single-center experience. Postepy Kardiol Interwencyjnej. 2020;16(3):235-243.  https://doi.org/10.5114/aic.2020.99257
  20. Góreczny S, Dryżek P, Moszura T, et al. Magnetic resonance and computed tomography imaging fusion for live guidance of percutaneous pulmonary valve implantation. Postepy Kardiol Interwencyjnej. 2018;14(4):413-421.  https://doi.org/10.5114/aic.2018.79871
  21. Miliaresis C, Beker S, Gewitz M. Cardiopulmonary stress testing in children and adults with congenital heart disease. Cardiol Rev. 2014;22(6):275-278.  https://doi.org/10.1097/CRD.0000000000000039
  22. Ansari MM, Cardoso R, Garcia D, et al. Percutaneous Pulmonary Valve Implantation: Present Status and Evolving Future. J Am Coll Cardiol. 2015;66(20):2246-2255. https://doi.org/10.1016/j.jacc.2015.09.055
  23. Delaney JW, Goldstein BH, Bishnoi RN, et al. PARCS Investigators. Covered CP Stent for Treatment of Right Ventricular Conduit Injury During Melody Transcatheter Pulmonary Valve Replacement. Circ Cardiovasc Interv. 2018;11(10):e006598. https://doi.org/10.1161/CIRCINTERVENTIONS.118.006598
  24. Gillespie MJ, Dori Y, Harris MA, et al. Bilateral branch pulmonary artery melody valve implantation for treatment of complex right ventricular outflow tract dysfunction in a high-risk patient. Circ CardiovascInterv. 2011;4(4):e213. https://doi.org/10.1161/CIRCINTERVENTIONS.111.962373
  25. Kim JY, Kim SH, Jang SI. Bilateral branch pulmonary artery Pulsta valve implantation for treatment of large right ventricular outflow tract in a high-risk patient. Catheter Cardiovasc Interv. 2021;98(5):923-927.  https://doi.org/10.1002/ccd.29857
  26. Hascoët S, Acar P, Boudjemline Y. Transcatheter pulmonary valvulation: current indications and available devices. Arch Cardiovasc Dis. 2014;107(11):625-634.  https://doi.org/10.1016/j.acvd.2014.07.048
  27. Wilson WM, Benson LN, Osten MD, Shah A, Horlick EM. Transcatheter Pulmonary Valve Replacement With the Edwards Sapien System: The Toronto Experience. JACC Cardiovasc Interv. 2015;8(14):1819-1827. https://doi.org/10.1016/j.jcin.2015.08.016
  28. Morray BH, McElhinney DB, Cheatham JP, et al. Risk of coronary artery compression among patients referred for transcatheter pulmonary valve implantation: a multicenter experience. Circ Cardiovasc Interv. 2013;6(5):535-542.  https://doi.org/10.1161/CIRCINTERVENTIONS.113.000202
  29. Lindsay I, Aboulhosn J, Salem M, Levi D. Aortic root compression during transcatheter pulmonary valve replacement. Catheter Cardiovasc Interv. 2016;88(5):814-821.  https://doi.org/10.1002/ccd.26547
  30. Faccini A, Butera G. Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with. Catheter Cardiovasc Interv. 2018;91(5):927-931.  https://doi.org/10.1002/ccd.27527
  31. Kenny D, Hijazi ZM, Kar S, et al. Percutaneous implantation of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position: early phase 1 results from an international multicenter clinical trial. J Am Coll Cardiol. 2011;58(21):2248-2256. https://doi.org/10.1016/j.jacc.2011.07.040
  32. Virk SA, Liou K, Chandrakumar D, Gupta S, Cao C. Percutaneous pulmonary valve implantation: A systematic review of clinical outcomes. Int J Cardiol. 2015;201:487-489.  https://doi.org/10.1016/j.ijcard.2015.08.119
  33. Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the u.s. Clinical trial. J Am Coll Cardiol. 2009;54(18):1722-1729. https://doi.org/10.1016/j.jacc.2009.06.034
  34. Cheatham JP, Hellenbrand WE, Zahn EM, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US melody valve investigational device exemption trial. Circulation. 2015;131(22):1960-1970. https://doi.org/10.1161/CIRCULATIONAHA.114.013588
  35. Chatterjee A., Bajaj N.S., McMahon W.S. et al. Transcatheter pulmonary valve implantation: a comprehensive systematic review and meta‐analyses of observational studies. J Am Heart Assoc. 2017;6:e006432. https://doi.org/10.1161/JAHA.117.006432
  36. Lurz P, Gaudin R, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2009;12(1):112-117.  https://doi.org/10.1053/j.pcsu.2009.01.011
  37. Haas NA, Carere RG, Kretschmar O, et al. Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system. International Journal of Cardiology. 2018;250:86-91.  https://doi.org/10.1016/j.ijcard.2017.10.015
  38. Therrien J, Provost Y, Merchant N, et al. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am J Cardiol. 2005;95:779-782.  https://doi.org/10.1016/j.amjcard.2004.11.037
  39. Jones TK, Rome JJ, Armstrong AK, et al. Transcatheter Pulmonary Valve Replacement Reduces Tricuspid Regurgitation in Patients With Right Ventricular Volume/Pressure Overload. J Am Coll Cardiol. 2016;68(14):1525-1535. https://doi.org/10.1016/j.jacc.2016.07.734
  40. Rzayeva KA, Gorbatykh AV, Zhuravleva IYu, et al. Transcatheter surgery of residual right ventricular outflow tract stenosis. Russian Journal of Cardiology. 2021;26(8):4125. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4125
  41. Promphan W, Qureshi SA. What Interventional Cardiologists Are Still Leaving to the Surgeons? Front Pediatr. 2016;4:59.  https://doi.org/10.3389/fped.2016.00059
  42. Lin M-T, Chen C, Chen S, et al. Prognostic markers in patients undergoing transcatheter implantation of Venus P-valve: Experience in Taiwan. Journal of the Formosan Medical Association. 2021;120(5):1202-1211. https://doi.org/10.1016/j.jfma.2020.10.006
  43. Morgan G, Prachasilchai P, Promphan W, et al. Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experience. EuroIntervention. 2019;14(13):1363-1370. https://doi.org/10.4244/EIJ-D-18-00299
  44. PULSTA Transcatheter Pulmonary Valve Pre-Approval Study. https://clinicaltrials.gov/ct2/show/NCT03983512
  45. Lee SY, Kim GB, Kim SH, et al. Mid-term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2021;98(5):724-732.  https://doi.org/10.1002/ccd.29865
  46. Biernacka EK, Rużyłło W, Demkow M. Percutaneous pulmonary valve implantation — state of the art and Polish experience. Postepy Kardiol Interwencyjnej. 2017;13(1):3-9.  https://doi.org/10.5114/aic.2017.66180
  47. Cardoso R, Ansari M, Garcia D, et al. Prestenting for prevention of melody valve stent fractures: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2016;87(3):534-539.  https://doi.org/10.1002/ccd.26235
  48. Nordmeyer J, Ewert P, Gewillig M, et al. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation. Eur Heart J. 2019;40(27):2255-2264. https://doi.org/10.1093/eurheartj/ehz201
  49. McElhinney DB, Benson LN, Eicken A, et al. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6(3):292-300.  https://doi.org/10.1161/CIRCINTERVENTIONS.112.000087
  50. Van Dijck I, Budts W, Cools B, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015;101(10):788-793.  https://doi.org/10.1136/heartjnl-2014-306761
  51. Patel M, Malekzadeh-Milani S, Ladouceur M, Iserin L, Boudjemline Y. Percutaneous pulmonary valve endocarditis: incidence, prevention and management. Arch Cardiovasc Dis. 2014;107(11):615-624.  https://doi.org/10.1016/j.acvd.2014.07.052
  52. Eisen A, Shapira Y, Sagie A, Kornowski R. Infective endocarditis in the transcatheter aortic valve replacement era: comprehensive review of a rare complication. Clin Cardiol. 2012;35(11):E1-5.  https://doi.org/10.1002/clc.22052
  53. Wang C, Li YJ, Ma L, Pan X. Infective Endocarditis in a Patient with Transcatheter Pulmonary Valve Implantation. Int Heart J. 2019;60(4):983-985.  https://doi.org/10.1536/ihj.18-497

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.